ALR Technologies SG Ltd. (ALRTF): R&D Expense
$793.3K
Year ended 2025-12-31
+18.1%
3-year compound annual growth
-11.2%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $793.3K | -10.2% | 2026-04-30, From 2025-01-01 |
| 2024-12-31 | $883.9K | -37.1% | 2026-04-30, From 2024-01-01 |
| 2023-12-31 | $1.40M | +191.3% | 2026-04-30, From 2023-01-01 |
| 2022-12-31 | $482.1K | -3.4% | 2025-05-02, From 2022-01-01 |
| 2021-12-31 | $499.0K | -65.2% | 2024-07-01, From 2021-01-01 |
| 2020-12-31 | $1.43M | n/a | 2023-05-01, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| ALR Technologies SG Ltd. (ALRTF) | 2025-12-31 | $793.3K | -10.2% |
| Odyssey Health, Inc. (ODYY) | 2025-07-31 | $0 | -100.0% |
| RetinalGenix Technologies Inc. (RTGN) | 2025-12-31 | $83.0K | -77.8% |
| Global Innovative Platforms Inc. (GIPL) | 2025-09-30 | $382.8K | n/m |
| Sigyn Therapeutics, Inc. (SIGY) | 2024-12-31 | $773.3K | -3.1% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
| Vivos Inc (RDGL) | 2025-12-31 | $352.2K | +8.5% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $484.9K | +64.7% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
Compare ALRTF, ODYY, RTGN, GIPL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗